ES2106169T3 - Anticuerpos monoclonales especificos del cd4 y que no provocan agotamiento, destinados para el tratamiento de diabetes mellitus dependiente de insulina (idmm). - Google Patents
Anticuerpos monoclonales especificos del cd4 y que no provocan agotamiento, destinados para el tratamiento de diabetes mellitus dependiente de insulina (idmm).Info
- Publication number
- ES2106169T3 ES2106169T3 ES92902288T ES92902288T ES2106169T3 ES 2106169 T3 ES2106169 T3 ES 2106169T3 ES 92902288 T ES92902288 T ES 92902288T ES 92902288 T ES92902288 T ES 92902288T ES 2106169 T3 ES2106169 T3 ES 2106169T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- monoclonal antibodies
- idmm
- diabetes mellitus
- intended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 title abstract 2
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ANTICUERPOS MONOCLONALES ESPECIFICOS CD-4 PUEDEN USARSE EN EL TRATAMIENTO DE LA DIABETES MELLITUS DEPENDIENTE DE LA INSULINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919100741A GB9100741D0 (en) | 1991-01-14 | 1991-01-14 | Treatment of disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2106169T3 true ES2106169T3 (es) | 1997-11-01 |
Family
ID=10688399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92902288T Expired - Lifetime ES2106169T3 (es) | 1991-01-14 | 1992-01-14 | Anticuerpos monoclonales especificos del cd4 y que no provocan agotamiento, destinados para el tratamiento de diabetes mellitus dependiente de insulina (idmm). |
Country Status (10)
Country | Link |
---|---|
US (1) | US5670150A (es) |
EP (1) | EP0567490B1 (es) |
JP (1) | JP3168005B2 (es) |
AT (1) | ATE156711T1 (es) |
AU (1) | AU668081B2 (es) |
CA (1) | CA2100462C (es) |
DE (1) | DE69221605T2 (es) |
ES (1) | ES2106169T3 (es) |
GB (1) | GB9100741D0 (es) |
WO (1) | WO1992011869A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0708902A2 (pt) * | 2006-03-16 | 2011-06-14 | Genentech Inc | mÉtodos de tratar lupus usando anticorpos cd4 |
WO2010009129A2 (en) * | 2008-07-15 | 2010-01-21 | Genentech, Inc. | Methods of treating autoimmune diseases using cd4 antibodies |
US20160158352A1 (en) * | 2013-07-10 | 2016-06-09 | The United States of America, as represented by the Secretary, Department of Health & Human Servic | Apoptotic cell-mediated induction of antigen specific regulatory t-cells for the therapy of autoimmune diseases in animals and humans |
KR20190120987A (ko) * | 2018-04-17 | 2019-10-25 | 국립암센터 | 고갈성 항 cd4 단일클론항체를 포함하는 항암 t 세포치료제 보조용 조성물 및 이의 용도 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69020914T2 (de) * | 1989-01-23 | 1996-03-07 | Abbott Lab | Monoklonale Antikörper von Ratten gegen menschliche Antigene und Verfahren zu deren Herstellung. |
GB8912497D0 (en) * | 1989-05-31 | 1989-07-19 | Cobbold Stephen P | Monoclonal antibodies |
-
1991
- 1991-01-14 GB GB919100741A patent/GB9100741D0/en active Pending
-
1992
- 1992-01-14 EP EP92902288A patent/EP0567490B1/en not_active Expired - Lifetime
- 1992-01-14 WO PCT/GB1992/000074 patent/WO1992011869A1/en active IP Right Grant
- 1992-01-14 DE DE69221605T patent/DE69221605T2/de not_active Expired - Lifetime
- 1992-01-14 JP JP50277792A patent/JP3168005B2/ja not_active Expired - Fee Related
- 1992-01-14 AT AT92902288T patent/ATE156711T1/de not_active IP Right Cessation
- 1992-01-14 AU AU11647/92A patent/AU668081B2/en not_active Ceased
- 1992-01-14 CA CA002100462A patent/CA2100462C/en not_active Expired - Lifetime
- 1992-01-14 ES ES92902288T patent/ES2106169T3/es not_active Expired - Lifetime
-
1995
- 1995-05-08 US US08/436,843 patent/US5670150A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0567490B1 (en) | 1997-08-13 |
DE69221605T2 (de) | 1998-02-12 |
CA2100462C (en) | 2003-06-17 |
AU1164792A (en) | 1992-08-17 |
JP3168005B2 (ja) | 2001-05-21 |
AU668081B2 (en) | 1996-04-26 |
EP0567490A1 (en) | 1993-11-03 |
ATE156711T1 (de) | 1997-08-15 |
JPH06504283A (ja) | 1994-05-19 |
CA2100462A1 (en) | 1992-07-15 |
WO1992011869A1 (en) | 1992-07-23 |
DE69221605D1 (de) | 1997-09-18 |
US5670150A (en) | 1997-09-23 |
GB9100741D0 (en) | 1991-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68929217T2 (de) | Insulinotropes hormon | |
AR001811A1 (es) | Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones | |
DE19375061I2 (de) | Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung. | |
ES2077869T3 (es) | Policitraconimidas y poliitaconimidas que contienen poli(sulfuro). | |
NO883837L (no) | Anordning til avgivelse av et middel i et foerste tidsrom etterfulgt av et andre, lengre tidsrom. | |
ES2153469T3 (es) | Compuestos con propiedades para liberar la hormona del crecimiento. | |
DK0533898T3 (da) | Fremgangsmåder og sammensætninger til behandling af diabetes mellitus, hypoglykæmi og andre tilstande | |
IT8709354A0 (it) | Siringa per iniezioni,in specie endovenose,realizzata per poteressere usata una sola volta,senza possibilita' di riaspirazione. | |
UA26056C2 (uk) | Пристрій для еhергетичhої активації хребта | |
PT73291B (en) | Process for the preparation of novel peptides | |
ES2131122T3 (es) | Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina. | |
ES2174838T3 (es) | Metodo para aumentar la absorcion del intestino. | |
ES2106169T3 (es) | Anticuerpos monoclonales especificos del cd4 y que no provocan agotamiento, destinados para el tratamiento de diabetes mellitus dependiente de insulina (idmm). | |
FR2351080B1 (es) | ||
MX9206135A (es) | Metodos | |
Devlin | Evidence for the existence of an IgM immuno-globulin to insulin | |
ES259684A2 (es) | Procedimiento para la preparaciën de nuevos colorantes azëicos | |
Swann | Earthlight | |
CO4290483A1 (es) | Articulo desechable integral para la contencion de desperdicios | |
Nishikawa | Studies on the “Wakame”, Undaria pinnatifida, culture in the Ariake Sea-V Estimation of growth and bleaching tips | |
Virella et al. | Progress in clinical and biological research. Volume 5—Trace components of plasma: Edited by GA Jamieson and TJ Greenwalt. Alan R. Liss, New York, 1976, 440 pp. $37.50 | |
JPS53142829A (en) | Delivery and recognizing system for real time graph | |
ES56169U (es) | Ampolla de inyección | |
GB918208A (en) | Improvements in or relating to conveyors | |
KR890012643A (ko) | 루신(Leucine)에 의한 생체에너지원 대체 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 567490 Country of ref document: ES |